CASE REPORTS

39
In a single pediatric cystic fibrosis (CF) program, we found 4 pediatric patients in whom 40 Trichosporon mycotoxinivorans was isolated. All had had persistently positive cultures for 41 Trichosporan spp. at the time T. mycotoxinivorans was confirmed. All patients had severe CFTR showed consistently poor response to intravenous antibiotics after several consecutive courses of 51 therapy for pulmonary exacerbation and was treated with antifungal therapy. Voriconazole was 52 associated with intolerable photosensitivity, and he was subsequently treated with inhaled 53 amphotericin B, with a reduction in pulmonary exacerbation frequency but not improvement in 54 pulmonary function, which had declined over time. Case 4 had one episode of pulmonary 55 exacerbation 3 years after initial isolation, and had recovered completely. 
63
Prior to this study, respiratory specimens from these patients had multiple positive growth of 64 organisms identified as Trichosporon spp. based on phenotypic characteristics (4). Since none of 65 these previously obtained isolates had been saved, their true identification cannot be confirmed.
66
From January of 2013, isolates were also tested using the MALDI-TOF system (Bruker confirmed by using a combination of phenotypic characterization and DNA sequencing of the 81 ITS and D1/D2 targets (100% identity for all four isolates). Subsequently, more isolates from 82 these patients continued to be identified as T. mycotoxinivorans using the MALDI-TOF. isolates, its utility in identifying this particular organism has not been studied (11) (12) (13) . We have 140 found that using the MALDI-TOF method, colonies of these organisms can be identified in just 1 141 hour. Due to the limitation of the relatively low number of clinical isolates tested in the study 142 and limited availability of reference materials, we were unable to perform an extended method 143 validation. Further studies focusing on the MOLDI-TOF performance specifically on this 144 species should provide useful information to possibly allow the method to be used routinely.
146
In summary, we describe a clinical case series of patients with cystic fibrosis and T. 
